Suhr
					
						 - "Background Regorafenib is an inhibitor of multiple kinases with aberrant expression and activity in neuroblastoma tumours that have potential roles in neuroblastoma pathogenesis. Methods We evaluated neuroblastoma […]"View
					
				 
				Active 8 months, 3 weeks ago